These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1300596)

  • 1. Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody.
    Castagna M; Viacava P; Turchi V; Rughetti A; Nuti M; Squartini F
    Pathol Res Pract; 1992 Dec; 188(8):1002-8. PubMed ID: 1300596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
    Castagna M; Nuti M; Squartini F
    Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
    Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
    Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
    Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
    Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical demonstration of calmodulin and its activated forms in normal and carcinomatous human mammary tissue.
    Tuccari G; Rizzo A; Barresi G
    Eur J Histochem; 1993; 37(1):59-64. PubMed ID: 7682869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ; House D
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.